financetom
Business
financetom
/
Business
/
Desjardins Comments on Bank of Canada's Governor Speech on Thursday
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Desjardins Comments on Bank of Canada's Governor Speech on Thursday
Feb 7, 2025 4:12 AM

06:34 AM EST, 02/07/2025 (MT Newswires) -- After a weekend on the brink of a full-blown trade war, Bank of Canada Governor Tiff Macklem sounded slightly more hawkish than expected in a speech late Thursday, noted Desjardins.

Governor Macklem acknowledged that the threat of United States tariffs is already affecting business and household uncertainty, which will weigh on economic activity.

However, the governor went on to strike a cautious tone regarding how much easing the BoC is willing to deliver if significant broad-based tariffs are applied, said the bank.

While no one should expect monetary policymakers to cut rates as much as they would in a typical recession because of the countervailing pressures on inflation, his mention of public disappointment and frustration might raise some eyebrows, pointed out Desjardins.

It's obvious that Macklem wanted to be clear about the limitations of monetary policy in the event of a tariff shock, stated the bank. The governor highlighted that officials "need to avoid the temptation to overload monetary policy by expecting more of it than it can deliver."

That's seemingly a lesson learned from the BoC's strategy during the COVID-19 pandemic, in which forward guidance and quantitative easing were used too generously, it added.

That said, if a trade war breaks out and 25% tariffs are applied to most Canadian exports, the bank's view that the BoC would cut the policy rate down to 1.50% remains intact. In past recessions, the BoC has needed to trim the policy rate by 400bps-500bps, much more than what Desjardins is expecting.

As a result, the bank believes its forecast strikes the appropriate balance. The somewhat hawkish tone does, however, have Dedinssjar on the fence about a 25bps cut in March if no tariffs have been levied yet.

While the governor briefly mentioned the negative economic impacts of tariff threats, he did nothing to confirm market pricing for another 25bps rate cut, added Desjardins. That's a bit surprising given the events over the weekend and the fact that the 3.00% policy rate is still above the 2.75% midpoint of the BoC's estimated neutral rate range.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Connexi Expands Global Supply Chain Capabilities with Acquisition of Crown Agents Inspections Private Limited
Connexi Expands Global Supply Chain Capabilities with Acquisition of Crown Agents Inspections Private Limited
Sep 23, 2025
WASHINGTON and NEW DELHI, Sept. 23, 2025 /PRNewswire/ -- Connexi, Chemonics International's supply chain subsidiary, today announced the acquisition of Crown Agents Inspections Private Limited, or CA Inspections, a leading quality assurance and inspection services provider in India. The acquisition strengthens Connexi's ability to deliver end-to-end supply chain solutions, expanding its reach in Asia and enhancing its capacity for product...
Neurocrine Biosciences Says Ingrezza Shows Earlier Remission of Tardive Dyskinesia Symptoms
Neurocrine Biosciences Says Ingrezza Shows Earlier Remission of Tardive Dyskinesia Symptoms
Sep 23, 2025
09:29 AM EDT, 09/23/2025 (MT Newswires) -- Neurocrine Biosciences ( NBIX ) said Tuesday that a phase 4 open-label study confirmed robust rates of symptomatic remission of tardive dyskinesia with once-daily Ingrezza capsules. The analysis also showed sustained improvements in patient-reported outcomes among participants who achieved symptomatic remission, the company said. Shares of the company were down 1% in recent...
Solid Biosciences Signs Licensing Deal With Kinea Bio for AAV-SLB101 to Treat Muscular Dystrophy
Solid Biosciences Signs Licensing Deal With Kinea Bio for AAV-SLB101 to Treat Muscular Dystrophy
Sep 23, 2025
08:31 AM EDT, 09/23/2025 (MT Newswires) -- Solid Biosciences ( SLDB ) said Tuesday that it has signed a non-exclusive licensing and collaboration agreement with Kinea Bio to use Solid Biosciences' ( SLDB ) proprietary AAV-SLB101 to treat muscle tropism and reduced liver uptake. Under the terms of the deal, Solid has granted Kinea Bio a non-exclusive worldwide license to...
Midland Exploration Starts Follow Up Program On Its New Discovery Of Gold-Zinc-Silver Mineralization at Caniapisc Au Project
Midland Exploration Starts Follow Up Program On Its New Discovery Of Gold-Zinc-Silver Mineralization at Caniapisc Au Project
Sep 23, 2025
09:29 AM EDT, 09/23/2025 (MT Newswires) -- Midland Exploration ( MIDLF ) announced Tuesday the start of a follow-up exploration program on its new discovery of gold, zinc, and silver on its Caniapisc Au project, in the Eeyou Istchee James Bay and Caniapiscau regions, and also announced map designation of two new projects in the same area. A statement noted...
Copyright 2023-2026 - www.financetom.com All Rights Reserved